• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者胸腺切除术后抗乙酰胆碱受体抗体水平降低。临床相关性。

Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.

作者信息

Kuks J B, Oosterhuis H J, Limburg P C, The T H

机构信息

Department of Neurology, University Hospital Groningen, The Netherlands.

出版信息

J Autoimmun. 1991 Apr;4(2):197-211. doi: 10.1016/0896-8411(91)90018-8.

DOI:10.1016/0896-8411(91)90018-8
PMID:1883480
Abstract

Clinical course and changes in serum levels of antibodies to the acetylcholine receptor (a-AChR) were followed in 82 patients with myasthenia gravis during a period of 1-8 years after thymectomy. Decrease in a-AChR immediately after thymectomy was influenced by changes in a total IgG. Immunosuppressive medication affected serum a-AChR at all points of time. In a subgroup of 41 patients without thymoma who had no immunosuppressive drugs, there was a steady decrease in a-AChR concomitant with clinical improvement from 6 weeks after thymectomy.

摘要

对82例重症肌无力患者在胸腺切除术后1至8年期间的临床病程及血清抗乙酰胆碱受体抗体(a-AChR)水平变化进行了跟踪。胸腺切除术后a-AChR的立即下降受总IgG变化的影响。免疫抑制药物在所有时间点均影响血清a-AChR。在41例无胸腺瘤且未使用免疫抑制药物的患者亚组中,自胸腺切除术后6周起,a-AChR持续下降,同时临床症状改善。

相似文献

1
Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.重症肌无力患者胸腺切除术后抗乙酰胆碱受体抗体水平降低。临床相关性。
J Autoimmun. 1991 Apr;4(2):197-211. doi: 10.1016/0896-8411(91)90018-8.
2
MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.乙酰胆碱受体抗体血清阳性重症肌无力与乙酰胆碱受体抗体血清阴性重症肌无力中的肌肉特异性激酶抗体
Neurology. 2004 Jun 8;62(11):2132-3. doi: 10.1212/01.wnl.0000129274.12702.92.
3
The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.不同抗体的存在及胸腺病理对全身型重症肌无力患者临床结局的预测价值。
Clin Neurol Neurosurg. 2013 Apr;115(4):432-7. doi: 10.1016/j.clineuro.2012.06.013. Epub 2012 Jul 6.
4
[Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients].[胸腺瘤性与非胸腺瘤性重症肌无力的胸腺切除术:46例患者队列分析]
Rev Neurol. 2020 Mar 16;70(6):213-219. doi: 10.33588/rn.7006.2019411.
5
Frequency and features of myasthenia gravis developing after thymectomy.胸腺瘤切除术后发生重症肌无力的频率和特征。
Eur J Neurol. 2020 Jan;27(1):175-180. doi: 10.1111/ene.14052. Epub 2019 Aug 12.
6
Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.乙酰胆碱受体抗体与重症肌无力患者胸腺切除术后的临床反应
Neurology. 1983 Oct;33(10):1276-82. doi: 10.1212/wnl.33.10.1276.
7
Myasthenia gravis appearing after thymectomy.胸腺瘤切除术后出现重症肌无力。
J Clin Neurosci. 2011 Jan;18(1):57-60. doi: 10.1016/j.jocn.2010.05.018.
8
Factors affecting response to thymectomy for myasthenia gravis.影响重症肌无力胸腺切除术疗效的因素。
J Thorac Cardiovasc Surg. 1981 Nov;82(5):720-8.
9
Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.重症肌无力中的抗兰尼碱受体抗体和他克莫司(FK506)
Neurology. 2004 May 25;62(10):1894-6. doi: 10.1212/01.wnl.0000125254.99397.68.
10
Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.胸腺切除术后重症肌无力:与胸腺瘤及抗乙酰胆碱受体抗体的关系
Ann Thorac Surg. 2008 Sep;86(3):941-5. doi: 10.1016/j.athoracsur.2008.04.070.

引用本文的文献

1
Thymic hyperplasia in myasthenia gravis: a narrative review.重症肌无力中的胸腺增生:一篇综述
Mediastinum. 2025 Jun 25;9:17. doi: 10.21037/med-25-12. eCollection 2025.
2
Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.重症肌无力患者胸腺和血液 Treg 的比较分析:胸腺上皮细胞导致胸腺免疫调节缺陷。
Front Immunol. 2020 May 6;11:782. doi: 10.3389/fimmu.2020.00782. eCollection 2020.
3
Unraveling the role of ectopic thymic tissue in patients undergoing thymectomy for myasthenia gravis.
揭示异位胸腺组织在重症肌无力患者胸腺切除术中的作用。
J Thorac Dis. 2019 Sep;11(9):4039-4048. doi: 10.21037/jtd.2019.08.109.
4
New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.自身免疫性重症肌无力的新途径和治疗靶点。
J Neuromuscul Dis. 2018;5(3):265-277. doi: 10.3233/JND-170294.
5
Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation.雌激素和促炎细胞因子之间的平衡调节参与胸腺生发中心形成的趋化因子产生。
Sci Rep. 2017 Aug 11;7(1):7970. doi: 10.1038/s41598-017-08631-5.
6
Mechanisms of Autoantibody-Induced Pathology.自身抗体诱导病理的机制。
Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017.
7
Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.重症肌无力中 Toll 样受体激活的研究进展:在新型实验模型开发中的应用。
Clin Rev Allergy Immunol. 2017 Feb;52(1):133-147. doi: 10.1007/s12016-016-8549-4.
8
Thymectomy for non-thymomatous myasthenia gravis.非胸腺瘤性重症肌无力的胸腺切除术
Cochrane Database Syst Rev. 2013 Oct 14;2013(10):CD008111. doi: 10.1002/14651858.CD008111.pub2.
9
Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.微阵列揭示了血清阳性和血清阴性重症肌无力患者胸腺中不同的基因特征以及CC趋化因子配体21在胸腺增生中的作用。
J Immunol. 2006 Dec 1;177(11):7868-79. doi: 10.4049/jimmunol.177.11.7868.
10
Vaccines against myasthenia gravis.抗重症肌无力疫苗。
Expert Opin Biol Ther. 2005 Jul;5(7):983-95. doi: 10.1517/14712598.5.7.983.